Columbia University Medical Center

“All of Us” Precision Medicine Exhibit to Visit CUMC

Learn about the NIH’s “All of Us” precision medicine project at CUMC on Tuesday, Aug. 22. The van will be parked at 168th Street and Fort Washington Avenue. The exhibit will be open between 9 a.m. and 3 p.m.

A traveling exhibit about the NIH’s “All of Us” precision medicine project will visit Columbia University Medical Center on Tuesday, Aug. 22, to raise awareness about the project and invite community members to participate. The All of Us van, parked at 168th Street and Fort Washington Avenue, will be open from 9 a.m. to 3 p.m.

The “All of Us” project, part of the NIH’s Precision Medicine Initiative, is an ambitious effort to gather data from 1 million or more people living in the United States to accelerate research and improve health. The program is open to people, healthy and sick, from all communities. Unlike a single research study focused on a specific disease or community, “All of Us” will serve as a national research resource to inform thousands of studies, covering a wide range of health conditions.

Seven health provider organizations across the country have been selected by the NIH to enroll participants in “All of Us.” Full participation includes three health surveys, permission for access to electronic medical record data, physical measurements, and blood and urine collection. Columbia University Medical Center is the lead institution for the New York City Consortium, comprised of Columbia, Weill Cornell Medicine, NYC Health + Hospitals|Harlem Hospital, and NewYork-Presbyterian.

“”All of Us” is important to shaping the future of health in the United States,” says David Goldstein, PhD, director of the Institute for Genomic Medicine at Columbia University, John E. Borne Professor of Genetics and Development, and principal investigator of the NYC Consortium.

“We’re excited to see how this research program will bring together communities throughout the United States to drive new discoveries, which may lead to earlier disease identification, more precise treatment solutions, and better health outcomes in the future.”

To learn more about the program, including what it means to be a participant, please visit joinallofus.org or join now.